Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 26
Filter
1.
Mem. Inst. Oswaldo Cruz ; 115: e190357, 2020. graf
Article in English | LILACS | ID: biblio-1091235

ABSTRACT

BACKGROUND Viruses can modulate intracellular signalling pathways to complete their infectious cycle. Among these, the PI3K/Akt pathway allows prolonged survival of infected cells that favours viral replication. GSK3β, a protein kinase downstream of PI3K/Akt, gets inactivated upon activation of the PI3K/Akt pathway, and its association with viral infections has been recently established. In this study, the role of GSK3β during Dengue virus-2 (DENV-2) infection was investigated. METHODS GSK3β participation in the DENV-2 replication process was evaluated with pharmacological and genetic inhibition during early [0-12 h post-infection (hpi)], late (12-24 hpi), and 24 hpi in Huh7 and Vero cells. We assessed the viral and cellular processes by calculating the viral titre in the supernatants, In-Cell Western, western blotting and fluorescence microscopy. RESULTS Phosphorylation of GSK3β-Ser9 was observed at the early stages of infection; neither did treatment with small molecule inhibitors nor pre-treatment prior to viral infection of GSK3β reduce viral titres of the supernatant at these time points. However, a decrease in viral titres was observed in cells infected and treated with the inhibitors much later during viral infection. Consistently, the infected cells at this stage displayed plasma membrane damage. Nonetheless, these effects were not elicited with the use of genetic inhibitors of GSK3β. CONCLUSIONS The results suggest that GSK3β participates at the late stages of the DENV replication cycle, where viral activation may promote apoptosis and release of viral particles.


Subject(s)
Animals , Virus Replication/physiology , Dengue Virus/enzymology , Glycogen Synthase Kinases/antagonists & inhibitors , Glycogen Synthase Kinases/physiology , Phosphorylation/physiology , Signal Transduction , Blotting, Western , Apoptosis/physiology , Aedes/cytology , Cell Line, Tumor , Microscopy, Fluorescence
2.
Rev. Soc. Bras. Med. Trop ; 52: e20180511, 2019. graf
Article in English | LILACS | ID: biblio-1003127

ABSTRACT

Abstract INTRODUCTION: Insect cell cultures play an essential role in understanding arboviral replication. However, the replicative efficiency of some of these viruses such as dengue (DENV), yellow fever (YFV), and chikungunya (CHIKV) in a new cellular substrate (Lulo) and in the other two recognized cell lines has not been comparatively assessed. METHODS: Vero, C6/36, and Lulo cell lines were infected with DENV, YFV, and CHIKV. The viral progeny was quantified through plaque assays and quantitative reverse transcription-polymerase chain reaction, while for DENV2, the findings were confirmed by immunofluorescence antibody assay. RESULTS: The higher DENV2 titer (from multiplicity of infection 0.001) was obtained on day four post-infection in C6/36 and on day six in Vero cells, while the Lulo cell line was almost impossible to infect under the same conditions. However, C6/36 showed the highest values of viral RNA production compared to Vero cells, while the quantification of the viral RNA in Lulo cells showed high levels of viral genomes, which had no correlation to the infectious viral particles. CONCLUSIONS: C6/36 was the most efficient cell line in the alpha and flavivirus production, followed by Vero cells. Thus, Lulo cells may be a useful substrate to study the mechanisms by which cells evade viral replication.


Subject(s)
Animals , Virus Replication/physiology , Yellow fever virus/physiology , Chikungunya virus/physiology , Dengue Virus/physiology , Insecta/virology , Time Factors , Vero Cells , Chlorocebus aethiops , Cricetinae , Reverse Transcriptase Polymerase Chain Reaction
3.
Biol. Res ; 52: 47-47, 2019. ilus
Article in English | LILACS | ID: biblio-1505767

ABSTRACT

Rubella or German measles is an infection caused by rubella virus (RV). Infection of children and adults is usually characterized by a mild exanthematous febrile illness. However, RV is a major cause of birth defects and fetal death following infection in pregnant women. RV is a teratogen and is a major cause of public health concern as there are more than 100,000 cases of congenital rubella syndrome (CRS) estimated to occur every year. Several lines of evidence in the field of molecular biology of RV have provided deeper insights into the teratogenesis process. The damage to the growing fetus in infected mothers is multifactorial, arising from a combination of cellular damage, as well as its effect on the dividing cells. This review focuses on the findings in the molecular biology of RV, with special emphasis on the mitochondrial, cytoskeleton and the gene expression changes. Further, the review addresses in detail, the role of apoptosis in the teratogenesis process.


Subject(s)
Humans , Female , Pregnancy , Pregnancy Complications, Infectious/virology , Rubella/complications , Rubella virus/physiology , Congenital Abnormalities/virology , Rubella Syndrome, Congenital/virology , Teratogenesis , Rubella/virology , Virus Replication/physiology , Signal Transduction , Apoptosis/physiology , Mitochondria/virology
4.
Mem. Inst. Oswaldo Cruz ; 112(4): 281-291, Apr. 2017. graf
Article in English | LILACS | ID: biblio-841788

ABSTRACT

BACKGROUND Dengue is considered one of the world’s most important mosquito-borne diseases. MicroRNAs (miRNAs) are small non-coding single-stranded RNAs that play an important role in the regulation of gene expression in eukaryotes. Although miRNAs possess antiviral activity against many mammalian-infecting viruses, their involvement in Dengue virus (DENV) replication remains poorly understood. OBJECTIVE To determine the role of miR-484 and miR-744 in DENV infection and to examine whether DENV infection alters the expression of both miRNAs. METHODS We used bioinformatics tools to explore the relationship between DENV and cellular miRNAs. We then overexpressed miR-484 or miR-744 in Vero cells to examine their role in DENV replication using flow cytometry, reverse transcriptase quantitative polymerase chain reaction (RT-qPCR), and western blotting. FINDINGS We found several cellular miRNAs that target a conserved region within the 3′ untranslated region (3′ UTR) of the genome of the four DENV serotypes and found that overexpression of miR-484 or miR-744 inhibits infection by DENV-1 to DENV-4. Furthermore, we observed that DENV RNA might be involved in the downregulation of endogenous miR-484 and miR-744. CONCLUSION Our study identifies miR-484 and miR-744 as two possible restriction host factors against DENV infection. However, further studies are needed to directly verify whether miR-484 and miR-744 both have an anti-DENV effect in vivo.


Subject(s)
Animals , Virus Replication/physiology , Virus Replication/genetics , Chlorocebus aethiops , Gene Expression Regulation/genetics , Blotting, Western , Polymerase Chain Reaction , Computational Biology , Untranslated Regions , Untranslated Regions/physiology , Dengue Virus/physiology , Dengue Virus/genetics , MicroRNAs/metabolism , Flow Cytometry
5.
Biomédica (Bogotá) ; 37(1): 131-140, ene.-feb. 2017. graf
Article in Spanish | LILACS | ID: biblio-888451

ABSTRACT

Resumen Introducción: El dengue es una enfermedad causada por uno de los cuatro serotipos del virus del dengue (DENV) y es endémica en, aproximadamente, 130 países. Su incidencia ha aumentado notablemente en las últimas décadas, así como la frecuencia y la magnitud de los brotes. A pesar de los esfuerzos, no existen tratamientos profilácticos ni terapéuticos contra la enfermedad y, en ese contexto, el estudio de los procesos que gobiernan el ciclo de infección del DENV es esencial para desarrollar vacunas o terapias antivirales. Una de las moléculas del DENV más prometedoras es la proteína no estructural 3 (NS3), la cual es indispensable para la replicación viral y es uno de los principales blancos inmunológicos durante la infección. Objetivo: Producir anticuerpos policlonales para contribuir a los futuros estudios sobre las interacciones entre la proteína NS3 y otras proteínas celulares. Materiales y métodos: Se expresaron dos proteínas recombinantes del dominio helicasa de NS3 del DENV de serotipo 2, las cuales se emplearon para inmunizar ratas y producir anticuerpos policlonales. Resultados: Los anticuerpos producidos fueron útiles en ensayos de Western blot e inmunofluorescencia y se reportó por primera vez un anticuerpo policlonal anti-NS3 que permitió la inmunoprecipitación de la proteína viral y la detecta con Western blot sin necesidad de inducir sobreexpresión de NS3 o de usar extractos de células marcados metabólicamente con radioisótopos. Conclusión: Las proteínas recombinantes expresadas y los anticuerpos producidos constituyen herramientas valiosas para estudiar procesos infecciosos del DENV que involucren a la proteína NS3 y evaluar pruebas dirigidas a interferir las funciones de esta proteína.


Abstract Introduction: Dengue is a disease caused by one of four serotypes of the dengue virus (DENV) and is endemic in approximately 130 countries. The incidence of dengue has increased dramatically in recent decades, as well as the frequency and magnitude of outbreaks. Despite all efforts, there are no prophylactic or therapeutic treatments for the disease. Accordingly, research on the processes governing the DENV infection cycle is essential to develop vaccines or antiviral therapies. One of the most attractive DENV molecules to investigate is nonstructural protein 3 (NS3), which is essential for viral replication and a major immune target for infection. Objective: To produce antibodies to support future studies on NS3 and its cellular interactions with other proteins. Materials and methods: Two recombinant proteins of the helicase domain of DENV NS3 serotype 2 were expressed, and used to immunize mice and produce polyclonal antibodies. Results: The antibodies produced were useful in Western blot and immunofluorescence tests. We report an NS3 antibody that immunoprecipitates the viral protein and detects it in Western blot with no need to over-express it or use cell extracts with metabolic radiolabeling.


Subject(s)
Animals , Humans , Mice , Virus Replication/physiology , Viral Nonstructural Proteins/genetics , Viral Nonstructural Proteins/metabolism , Dengue/virology , Dengue Virus/immunology , Antibodies, Viral/immunology , Virus Replication/genetics , Virus Replication/immunology , Serine Endopeptidases/genetics , Serine Endopeptidases/metabolism , Serine Endopeptidases/chemistry , Blotting, Western , Viral Nonstructural Proteins/chemistry , RNA Helicases/genetics , RNA Helicases/metabolism , RNA Helicases/chemistry , Antibodies, Viral/metabolism , Antibodies, Viral/chemistry
6.
Clin. biomed. res ; 37(3): 214-231, 2017. tab, ilus
Article in Portuguese | LILACS | ID: biblio-859835

ABSTRACT

A ingestão de bebidas alcoólicas é um evento socioculturalmente aceito em muitos países. Porém, o consumo frequente e descontrolado deste tipo de bebida configura o transtorno por uso de álcool (TUA). Esta condição causa agravos que podem afetar a sociedade de uma forma geral. O TUA também pode levar os pacientes a contraírem doenças. Entre estas, existe uma relação importante entre TUA e doenças infectocontagiosas, com destaque para a infecção pelo HIV e o posterior desenvolvimento da AIDS. Portanto, a presente pesquisa objetivou realizar uma revisão da literatura sobre as relações entre TUA e HIV/AIDS. A seleção do material científico foi efetuada tendo por base plataformas eletrônicas, tais como: Google Scholar, MEDLINE, LILACS, SciELO, NCBI / PUBMED, Scopus e Science Direct. O entendimento dos fatores relacionados ao TUA, principalmente em pacientes com HIV/AIDS, é de fundamental importância para a formulação e criação de estratégias de políticas públicas que visem reduzir esta possível relação (AU)


The ingestion of alcoholic beverages is socio-culturally accepted in many countries. However, frequent and uncontrolled consumption of this type of beverage constitutes alcohol use disorder (AUD). This condition may be harmful to society in general, and it can lead patients to contract other diseases. There is an important relationship between AUD and infectious diseases, with emphasis on HIV infection and the later development of AIDS. Therefore, the present research aimed to carry out a review of the literature on the relationship between AUD and HIV/AIDS. The selection of the scientific material was based on electronic platforms, such as Google Scholar, MEDLINE, LILACS, SciELO, NCBI/ PUBMED, Scopus and Science Direct. The understanding of the factors related to AUD, especially in patients with HIV/AIDS, is of fundamental importance for the formulation and creation of public policy strategies aimed at reducing this possible relationship (AU)


Subject(s)
Humans , Alcohol-Related Disorders/complications , HIV Infections/transmission , Alcohol Drinking/adverse effects , HIV Infections/chemically induced , Viral Load/physiology , Virus Replication/physiology
7.
Journal of Veterinary Science ; : 115-117, 2016.
Article in English | WPRIM | ID: wpr-110757

ABSTRACT

Newcastle disease viruses (NDVs) cause systemic diseases in chickens with high mortality. However, little is known about persistence of NDVs in contaminated tissues from infected birds. In this study, we examined viral replication in the feather pulp of chickens inoculated with viscerotropic velogenic NDV (vvNDV) genotype VII. Reverse transcription real-time PCR and immunohistochemistry were used to investigate viral persistence in the samples. vvNDV was detected in the oropharynx and cloaca and viral antigens were detected in the feathers, suggesting that feathers act as sources of viral transmission.


Subject(s)
Animals , Antigens, Viral/analysis , Chickens , Cloaca/virology , Feathers/virology , Microbial Viability , Newcastle Disease/transmission , Newcastle disease virus/isolation & purification , Oropharynx/virology , Poultry Diseases/transmission , Virus Replication/physiology
8.
Rev. chil. infectol ; 32(1): 58-70, feb. 2015. ilus
Article in Spanish | LILACS | ID: lil-742540

ABSTRACT

Herpes simplex viruses and humans have co-existed for tens of thousands of years. This long relationship has translated into the evolution and selection of viral determinants to evade the host immune response and reciprocally the evolution and selection of host immune components for limiting virus infection and damage. Currently there are no vaccines available to avoid infection with these viruses or therapies to cure them. Herpes simplex viruses are neurotropic and reside latently in neurons at the trigeminal and dorsal root ganglia, occasionally reactivating. Most viral recurrences are subclinical and thus, unnoticed. Here, we discuss the initial steps of infection by herpes simplex viruses and the molecular mechanisms they have developed to evade innate and adaptive immunity. A better understanding of the molecular mechanisms evolved by these viruses to evade host immunity should help us envision novel vaccine strategies and therapies that limit infection and dissemination.


Los virus herpes simplex y humanos co-existen desde decenas de miles de años. Esta prolongada relación se ha traducido en la evolución y selección de determinantes virales para evadir la respuesta inmune y recíprocamente la evolución y selección de componentes inmunes del hospedero para limitar la infección viral y el daño que producen. Actualmente no existen vacunas para evitar la infección de estos virus o terapias que la curen. Los virus herpes simplex son neurotrópicos y permanecen latentes en neuronas de ganglios trigémino y dorsales, reactivándose esporádicamente. La mayoría de las recurrencias por virus herpes simplex son sub-clínicas y por tanto pasan inadvertidas. Aquí discutimos los pasos iniciales de la infección porvirus herpes simplex y los mecanismos moleculares que estos virus han desarrollado para evadir la respuesta inmune innata y adaptativa. Una mejor comprensión de los mecanismos moleculares evolucionados por estos virus para evadir la respuesta inmune del hospedero deberían ayudarnos visualizar nuevas estrategias para desarrollar vacunas y terapias que limiten su infección y diseminación.


Subject(s)
Humans , Adaptive Immunity/immunology , Herpes Simplex/immunology , Immune Evasion , Simplexvirus/pathogenicity , Apoptosis/physiology , Interferon Type I/immunology , Simplexvirus/physiology , Virus Latency/physiology , Virus Replication/physiology
9.
Journal of Veterinary Science ; : 361-367, 2014.
Article in English | WPRIM | ID: wpr-194862

ABSTRACT

The objectives of the present study were to evaluate the anatomic localization of porcine reproductive and respiratory syndrome virus (PRRSV) in naturally infected pigs and to determine whether oral fluid could be used to detect the virus in infected animals. Two sows, seven 2-month-old grower pigs, and 70 6-month-old gilts were included in this study. PRRSV in sera and oral fluid were identified by nested reverse transcription PCR (nRT-PCR) while lung, tonsil, and tissue associated with oral cavity were subjected to nRT-PCR, immunohistochemistry, and in situ hybridization. In sows, PRRSV was identified in oral fluid and tonsils. PRRSV was also detected in oral fluid, tonsils, salivary glands, oral mucosa, and lungs of all seven grower pigs. However, viremia was observed in only two grower pigs. Double staining revealed that PRRSV was distributed in macrophages within and adjacent to the tonsillar crypt epithelium. In gilts, the North American type PRRSV field strain was detected 3 to 8 weeks after introducing these animals onto the farm. These results confirm previous findings that PRRSV primarily replicates in tonsils and is then shed into oral fluid. Therefore, oral fluid sampling may be effective for the surveillance of PRRSV in breeding herds.


Subject(s)
Animals , Female , Male , In Situ Hybridization/veterinary , Lung/virology , Palatine Tonsil/virology , Polymerase Chain Reaction/veterinary , Porcine Reproductive and Respiratory Syndrome/virology , Porcine respiratory and reproductive syndrome virus/physiology , Saliva/virology , Salivary Glands/virology , Swine/virology , Virus Replication/physiology
10.
Journal of Veterinary Science ; : 439-442, 2014.
Article in English | WPRIM | ID: wpr-194852

ABSTRACT

The ferret is an established animal model of influenza virus infection. Although viral replication in the upper respiratory tract is usually measured with consecutively collected nasal washes, daily evaluation of viral replication in the lung is limited because a large numbers of ferrets need to be sacrificed at consecutive time points. To overcome this limitation, we performed a virus quantification assay using bronchoalveolar lavage (BAL) fluid. This non-invasive BAL technique allows consecutive quantification of virus replication in the lungs of living ferrets. Our method can be used for the longitudinal evaluation of virus tropism in the lower respiratory tract.


Subject(s)
Animals , Female , Bronchoalveolar Lavage/veterinary , Disease Models, Animal , Ferrets/virology , Influenza A Virus, H3N2 Subtype/physiology , Orthomyxoviridae Infections/veterinary , Respiratory System/virology , Virus Replication/physiology
11.
Mem. Inst. Oswaldo Cruz ; 108(5): 554-562, ago. 2013. graf
Article in English | LILACS | ID: lil-680770

ABSTRACT

Interfering with cellular signal transduction pathways is a common strategy used by many viruses to create a propitious intracellular environment for an efficient replication. Our group has been studying cellular signalling pathways activated by the orthopoxviruses Vaccinia (VACV) and Cowpox (CPXV) and their significance to viral replication. In the present study our aim was to investigate whether the GTPase Rac1 was an upstream signal that led to the activation of MEK/ERK1/2, JNK1/2 or Akt pathways upon VACV or CPXV' infections. Therefore, we generated stable murine fibroblasts exhibiting negative dominance to Rac1-N17 to evaluate viral growth and the phosphorylation status of ERK1/2, JNK1/2 and Akt. Our results demonstrated that VACV replication, but not CPXV, was affected in dominant-negative (DN) Rac1-N17 cell lines in which viral yield was reduced in about 10-fold. Viral late gene expression, but not early, was also reduced. Furthermore, our data showed that Akt phosphorylation was diminished upon VACV infection in DN Rac1-N17 cells, suggesting that Rac1 participates in the phosphoinositide-3 kinase pathway leading to the activation of Akt. In conclusion, our results indicate that while Rac1 indeed plays a role in VACV biology, perhaps another GTPase may be involved in CPXV replication.


Subject(s)
Animals , Mice , Cowpox virus/physiology , MAP Kinase Signaling System/physiology , Signal Transduction/physiology , Vaccinia virus/physiology , Virus Replication/physiology , rac1 GTP-Binding Protein/physiology , Chlorocebus aethiops , Phosphorylation/physiology , Vero Cells , rac1 GTP-Binding Protein/metabolism
12.
Mem. Inst. Oswaldo Cruz ; 108(1): 36-40, Feb. 2013. graf, tab
Article in English | LILACS | ID: lil-666041

ABSTRACT

ELISA in situ can be used to titrate hepatitis A virus (HAV) particles and real-time polymerase chain reaction (RT-PCR) has been shown to be a fast method to quantify the HAV genome. Precise quantification of viral concentration is necessary to distinguish between infectious and non-infectious particles. The purpose of this study was to compare cell culture and RT-PCR quantification results and determine whether HAV genome quantification can be correlated with infectivity. For this purpose, three stocks of undiluted, five-fold diluted and 10-fold diluted HAV were prepared to inoculate cells in a 96-well plate. Monolayers were then incubated for seven, 10 and 14 days and the correlation between the ELISA in situ and RT-PCR results was evaluated. At 10 days post-incubation, the highest viral load was observed in all stocks of HAV via RT-PCR (10(5) copies/mL) (p = 0.0002), while ELISA revealed the highest quantity of particles after 14 days (optical density = 0.24, p < 0.001). At seven days post-infection, there was a significant statistical correlation between the results of the two methods, indicating equivalents titres of particles and HAV genome during this period of infection. The results reported here indicate that the duration of growth of HAV in cell culture must be taken into account to correlate genome quantification with infectivity.


Subject(s)
Animals , Defective Viruses/physiology , Enzyme-Linked Immunosorbent Assay/methods , Hepatitis A virus/physiology , Real-Time Polymerase Chain Reaction/methods , Virus Replication/physiology , Cell Line , Macaca mulatta , Time Factors , Viral Load , Viral Plaque Assay
13.
Braz. j. infect. dis ; 16(2): 146-152, May-Apr. 2012. tab
Article in English | LILACS | ID: lil-622735

ABSTRACT

Human herpesvirus type 6-(HHV-6) has been associated with morbidity after liver transplantation. OBJECTIVE: The aim of this study was to determine the HHV-6 seroprevalence among donor-recipient pairs, analyze the incidence of early active infection, its clinical manifestation, interaction with CMV, and the related morbidity in the first year after kidney transplantation. METHODS: 46 donor-recipient pairs had IgG evaluated by ELISA before transplantation: HHV-6(Pambio - USA) and CMV-(Roche - USA). A frozen whole blood sample collected weekly (from the 1st to the 6th week) was retrospectively tested for HHV-6 viral load (VL) determination by real time quantitative PCR (qPCR, Nanogen - Italy). Patients were preemptively surveyed for CMV by pp65 antigenemia (Ag, APAAP, immunohistochemistry, Biotest - Germany) from the 4th to the 12th week after transplantation. Active infection was defined as qPCR-HHV6+ (viral-load/mL-VL) and Ag+ (+cells/100.000 granulocytes), for HHV-6 and CMV, respectively. DCMV was defined as simultaneous positive antigenemia and suggestive signs/symptoms. Concerning +qPCR-HHV6, associated factors, clinical manifestation, interaction with CMV and morbidity were searched. RESULTS: Pre-transplant HHV-6 seroprevalence was significantly higher among kidney recipients compared to their donors (82.6x54.8%; p = 0.005 [3.9 (1.4-10.4)]). Active infection by this virus occurred in 26.1% (12/46), with no association with previous IgG (p = 0.412). Median VL was 125 copies/mL (53-11.264), and the median Ag was 21 +cells (2-740). There was no association between HHV-6 and CMV activation after transplantation (p = 0.441), neither concerning DCMV (p = 0.596). Median highest Ag+ and days of ganciclovir treatment were similar between qPCR-HHV6 + or - (p = 0.206 and p = 0.124, respectively). qPCR-HHV6+ was associated with higher incidence of bacterial (p = 0.009) and fungal (p = 0.001) infections, and higher number (p = 0.001) of hospital admission and longer duration of hospitalization over the first 6 and 12 months post-transplantation (p = 0.033 and p = 0.001). CONCLUSION: Latent HHV-6 infection is more common among recipients than donors before transplantation. Early active infection by this pathogen after transplantation does not increase DCMV incidence or severity during the first 3 months of follow-up. However, early HHV-6 replication is associated with other infections and hospitalizations in the first year.


Subject(s)
Adult , Female , Humans , Male , Cytomegalovirus Infections/virology , /physiology , Kidney Transplantation/adverse effects , Roseolovirus Infections/virology , Virus Replication/physiology , Cohort Studies , Enzyme-Linked Immunospot Assay , Immunoglobulin G/blood , Polymerase Chain Reaction , Retrospective Studies , Seroepidemiologic Studies , Viral Load
14.
Acta biol. colomb ; 11(2): 3-20, jul. 2006. ilus
Article in Spanish | LILACS | ID: lil-468995

ABSTRACT

El herpesvirus equino (EHV) es uno de los patógenos virales de mayor importancia en la industria equina mundial, debido a las grandes pérdidas económicas que acarrea. La enfermedad comúnmente asociada con el EHV se denomina rinoneumonitis equina y se caracteriza por ser una infección primaria del tracto respiratorio superior, que progresa a través de la mucosa; puede causar aborto en los últimos meses de gestación, muerte perinatal de potros, mortinatos y mieloencefalitis. La infección productiva es seguida por un estado de latencia viral, etapa en la cual el animal no presenta ningún signo clínico de enfermedad y no hay replicación viral. Bajo una situación de estrés, el virus puede reactivarse y caballos infectados infectar a otros caballos sanos. En esta revisión se presenta de manera sintetizada, los principales hallazgos relacionados con la replicación viral y patogénesis molecular del EHV, relacionando además las proteínas implicadas en la regulación de la replicación del genoma, todas las glicoproteínas estructurales que han sido estudiadas hasta el momento y que son el eje central de investigación de distintos grupos en el mundo. Se discute además, la verdadera importancia de la dispersión directa célulacélula del virus, la formación de placas, el crecimiento in vitro y en algunos casos, la asociación con la patogénesis, bien sea en un modelo animal o en el hospedero natural.


Subject(s)
Genome, Viral , Virus Replication/physiology , Virus Replication/genetics , Virus Replication/immunology
15.
Rev. argent. transfus ; 31(1/2): 43-55, ene.-jul. 2005. ilus, mapas, tab
Article in Spanish | LILACS | ID: lil-417864

ABSTRACT

El virus HTLV I/II es un retrovirus, muy antiguo, cuyo origen posiblemente sea su homólogo en los simios, quienes lo transmiten al humano y luego se difunde entre nuestra especie. Gracias a los adelantos científicos, se han podido establecer las tres probables entradas o rutas migratorias de nuestros antepasados entre los distintos continentes. Ellos lamentablemente desconocían que estaban infectados. En nuestros tiempos, este insignificante y tan pequeño virus presenta áreas endémicas en todo el mundo (inclusive Argentina) y es el responsable de dos enfermedades, la Paraparesia Espástica Tropical y la Leucemia T del adulto, ambas incurables. Se ha podido prevenir la diseminación del mismo por el desarrollo de pruebas de tamizaje o selección (enzimoinmunoensayo) y suplementarias (Western Blot), como también por el asesoramiento médico de los individuos infectados.


Subject(s)
Humans , HTLV-I Infections/diagnosis , HTLV-I Infections/epidemiology , HTLV-I Infections/history , HTLV-I Infections/therapy , HTLV-I Infections/transmission , HTLV-II Infections/diagnosis , HTLV-II Infections/epidemiology , HTLV-II Infections/history , HTLV-II Infections/therapy , HTLV-II Infections/transmission , Argentina/epidemiology , Phylogeny , Virus Replication/physiology , Survivors , Immunoenzyme Techniques/methods , Serologic Tests , Human T-lymphotropic virus 1/physiology , Human T-lymphotropic virus 1/ultrastructure , /physiology , /ultrastructure , Blotting, Western/methods
16.
Article in English | IMSEAR | ID: sea-16560

ABSTRACT

The accessory Nef protein is expressed by all primate lentiviruses--HIV-1,HIV-2 and simian immune deficiency virus (SIV). Its expression in the early stages of the viral life cycle ensures two basic attributes of HIV infection. These are T-cell activation and the establishment of a persistent state of infection. Nef has a positive effect on viral infection and replication by promoting the survival of infected cells. Its role in HIV persistence is based largely on the ability of Nef to downmodulate the surface levels of important molecules at the immune synapse. These include major histocompatibility complex-I (MHC I) and (MHC II) present on antigen-presenting cells (APCs) and target cells, and CD4 and CD28 present on helper T cells. In this review we present these biological properties of Nef from a mechanistic point of view, and relate them to the structural attributes and interactions of the Nef protein. A brief outline of the limited studies on Nef from Indian subtype C HIV-1 isolates is also presented.


Subject(s)
Amino Acid Sequence , Gene Products, nef/chemistry , HIV/pathogenicity , Molecular Sequence Data , Sequence Homology, Amino Acid , Virion/pathogenicity , Virus Replication/physiology , nef Gene Products, Human Immunodeficiency Virus
18.
Article in English | LILACS | ID: lil-339318

ABSTRACT

The means by which replication of viruses takes place is explained, as it helps in the understanding of how viruses spread in the blood and how antiretroviral drugs work. The most important viruses, from a health care workers point of view, are hepatitis B and C and human immunodefiency virus (HIV). Whether nuclear medicine has a role to play in the diagnosis of these viruses, and the oportunistic infections that go with them, is debatable. Several radiopharmaceuticals are extremely sensitive for infection and tumor imaging but lack specificity. Patients' treatment is often not based on the outcome of the investigation but rather on preset protocols. AIDS patients are put on prophylactic antibiotic treatment as protection against infections such as toxoplasmosis and pneumocystis carinii pneumonia and there is a poor prognosis for AIDS patients with tumors


Subject(s)
Humans , Male , Female , Hepatitis A , Hepatitis B , Radiopharmaceuticals , Virus Replication/physiology , Acquired Immunodeficiency Syndrome/diagnosis , Sensitivity and Specificity , AIDS-Related Opportunistic Infections
19.
Article in English | IMSEAR | ID: sea-44991

ABSTRACT

HSV is known to cause infection at various parts in the human body such as skin, mouth, eyes, genital area, and brain. In this study, the authors showed the possibility of HSV replication in Jurkat, a human leukemic T lymphocytes. Although the yield production was very low when compared to the other 2 epithelial cells, Vero and HEp-2 cells, the yield production could enhance after PHA activation. Delayed viral protein expression was observed in Jurkat cells. This might be the reason for low production. However, the exactly mechanism is unknown. Replication of viruses have been examined in a number of cell systems and the duration of successive steps in the replication cycle depends upon the types of cells, the virus strain, and the multiplicity of infection.


Subject(s)
Cells, Cultured , Culture Media , Fluorescent Antibody Technique, Indirect , Humans , Jurkat Cells/metabolism , Sensitivity and Specificity , Simplexvirus/growth & development , T-Lymphocytes/physiology , Viral Proteins/metabolism , Virus Replication/physiology
20.
São Paulo; s.n; 2001. 99 p. ilus, tab.
Thesis in Portuguese | LILACS, SES-SP | ID: lil-313785

ABSTRACT

O presente estudo visou a detecção de antígenos (AgHBe e AgHBx) do vírus da hepatite B (VHB) por método imuno-histoquímico Envision+peroxidase. Foi ainda pesquisada a distribuição e inter-relação entre estes antígenos, bem como com marcadores sorológicos de replicação viral (DNA-VHB, AgHBe), com AgHBc no tecido, e com os principais indicadores histológicos de estadiamento dos distúrbios da arquitetura hepática e o grau de atividade necro-inflamatória. A casuística compreendeu 196 amostras de fígado fixadas em formol e incluídas em parafina de pacientes com os varios estádios de hepatopatia crônica associada ao VHB. Os resultados mostraram positividade imuno-histoquímica para AgHBeem 63/196 (32,1 porcento) casos...


Subject(s)
Animals , Rabbits , Mice , Immunohistochemistry , Carcinoma, Hepatocellular , Hepatitis B , Hepatitis B Antibodies , Liver Diseases , Virus Replication/physiology , Biopsy , Immunoassay , Antibodies, Monoclonal , Data Interpretation, Statistical , Antigens, Differentiation , Biomarkers/blood
SELECTION OF CITATIONS
SEARCH DETAIL